USPTO serial 79359853
DRUGOME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 11, 2024
- Examiner
- WUDARSKY, MINDY CHEK
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DRUGOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Calculating machines, data processing equipment, computers; downloadable computer software for data aggregation automation, database creation, data analysis, data reporting and data visualization; downloadable computer software for providing, analyzing and generating reports; downloadable computer software for data processing; electronic apparatus, electronic equipment, downloadable computer software and programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; electronic apparatus, electronic equipment, downloadable computer software and programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research in support of data analysis and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest | ACTIVE | — |
| 035 | Advertising services; business management; business administration; providing office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; statistical analysis and reporting services using artificial intelligence and machine learning for business purposes in the pharmaceutical and biomedical fields; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data, all the foregoing for business purposes; systematization of data in computer databases; compilation of data for business analysis purposes, namely, compilation of information into computer databases for business data analysis purposes in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business data analysis and consultancy and statistical analysis for business purposes in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes | ACTIVE | — |
| 036 | Financial analysis; financial consulting; financial valuations and forecasting; financial analysis of statistics and data; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and clinical and post-market trials | ACTIVE | — |
| 042 | Scientific and technological services, namely, data aggregation automation, database creation, data analysis, data reporting and data visualization in the field of healthcare, pharmaceuticals, biomedical research, and for clinical trial and post-marketing and research and design relating thereto; analysis of technical data by computers, namely, data automation and collection service using proprietary software to evaluate, analyze and collect data, providing use of online non-downloadable software for analyzing data; pharmaceutical, biomedical, and biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing featuring software for use in data aggregation automation, database creation, data analysis, data reporting and data visualization; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data for data analysis, data reporting and data visualization; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sumitomo Pharma Co., Ltd.
- Other trademarks owned by Sumitomo Pharma Co., Ltd.
- Other trademarks owned by Sumitomo Pharma Co., Ltd.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Similar marks named DRUGOME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 14, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 21, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 21, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 11, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 3, 2024 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jun 16, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 11, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 11, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 7, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 26, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 26, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 6, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 17, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 17, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 17, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 17, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 17, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 23, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 22, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 22, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 21, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 21, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 15, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 14, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 13, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 9, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 6, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |